PLRX

Lily Cheung

Known title: Chief Human Resource OfficerCIK: 0001962207

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 1, 2026

Pliant Therapeutics Names New Chief Medical Officer. Pliant Therapeutics has appointed David Raben, M.D., as its new Chief Medical Officer. This leadership change is a standard corporate update for the company. The stock is currently trading within its 52-week range, with recent technical indicators showing a support rejection near $1.13.

this person other insiders at PLRX

Transaction History

PLRX▼ Sell$10K
PLRX▲ Buy$0
PLRX▼ Sell$42K
PLRX▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.